Suppr超能文献

转基因对大豆内源性过敏原水平的影响小于传统育种。

Transgenesis affects endogenous soybean allergen levels less than traditional breeding.

作者信息

Hill Ryan C, Fast Brandon J, Herman Rod A

机构信息

Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States.

Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268, United States.

出版信息

Regul Toxicol Pharmacol. 2017 Oct;89:70-73. doi: 10.1016/j.yrtph.2017.07.013. Epub 2017 Jul 15.

Abstract

The regulatory body that oversees the safety assessment of genetically modified (GM) crops in the European Union, the European Food Safety Authority (EFSA), uniquely requires that endogenous allergen levels be quantified as part of the compositional characterization of GM versions of crops, such as soybean, that are considered to be major allergenic foods. The value of this requirement for assessing food safety has been challenged for multiple reasons including negligible risk of altering allergen levels compared with traditional non-GM breeding. Scatter plots comparing the mean endogenous allergen levels in non-GM soybean isoline grain with the respective levels in GM grain or concurrently grown non-GM commercial reference varieties clearly show that transgenesis causes less change compared with traditional breeding. This visual assessment is confirmed by the quantitative fit of the line of identity (y = x) to the datasets. The current science on allergy does not support the requirement for quantifying allergen levels in GM crops to support safety assessment.

摘要

在欧盟,负责监督转基因作物安全性评估的监管机构——欧洲食品安全局(EFSA),有一项独特要求,即作为大豆等被视为主要致敏性食品的转基因作物成分特征描述的一部分,需对其内源过敏原水平进行量化。这项评估食品安全要求的价值受到了多方面质疑,包括与传统非转基因育种相比,改变过敏原水平的风险可忽略不计。将非转基因大豆近等基因系籽粒中的平均内源过敏原水平与转基因籽粒或同期种植的非转基因商业对照品种中的相应水平进行比较的散点图清楚地表明,与传统育种相比,转基因导致的变化更小。通过将恒等线(y = x)与数据集进行定量拟合,证实了这一视觉评估结果。当前关于过敏的科学研究并不支持为支持安全性评估而对转基因作物中的过敏原水平进行量化的要求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验